These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 26342407)

  • 61. The Anticancer Effects of Garlic Extracts on Bladder Cancer Compared to Cisplatin: A Common Mechanism of Action via Centromere Protein M.
    Kim WT; Seo SP; Byun YJ; Kang HW; Kim YJ; Lee SC; Jeong P; Song HJ; Choe SY; Kim DJ; Kim SK; Ha YS; Moon SK; Lee GT; Kim IY; Yun SJ; Kim WJ
    Am J Chin Med; 2018; 46(3):689-705. PubMed ID: 29595070
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Vascular endothelial-targeted therapy combined with cytotoxic chemotherapy induces inflammatory intratumoral infiltrates and inhibits tumor relapses after surgery.
    Judy BF; Aliperti LA; Predina JD; Levine D; Kapoor V; Thorpe PE; Albelda SM; Singhal S
    Neoplasia; 2012 Apr; 14(4):352-9. PubMed ID: 22577350
    [TBL] [Abstract][Full Text] [Related]  

  • 63. A "Prozone-Like" Effect Influences the Efficacy of the Monoclonal Antibody ABT-700 against the Hepatocyte Growth Factor Receptor.
    Vaidya KS; Oleksijew A; Tucker LA; Pappano WN; Anderson MG; Grinnell CM; Zhang Q; Heighton SJ; Mitten MJ; Mishra S; Palma JP; Wang J; Reilly EB; Boghaert ER
    Pharmacology; 2017; 100(5-6):229-242. PubMed ID: 28743107
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Analysis of the effect of promoter type and skin pretreatment on antigen expression and antibody response after gene gun-based immunization.
    Vij R; Lin Z; Schneider K; Seshasayee D; Koerber JT
    PLoS One; 2018; 13(6):e0197962. PubMed ID: 29856790
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Knocking down claudin receptors leads to a decrease in prostate cancer cell migration, cell growth, cell viability and clonogenic cell survival.
    Liu Q; Shen H; Naguib A; Weiss RM; Martin DT
    Mol Biomed; 2021 Oct; 2(1):31. PubMed ID: 35006480
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Selective cytotoxicity of drug-monoclonal antibody conjugates against murine bladder tumor cells.
    Iwasa S; Konishi E; Kondo K; Suzuki T; Akaza H; Niijima T
    Chem Pharm Bull (Tokyo); 1987 Mar; 35(3):1128-37. PubMed ID: 3607937
    [No Abstract]   [Full Text] [Related]  

  • 67. High-resolution study of the Xe 4d5/2:4d3/2 branching ratio.
    Ausmees A; Osborne SJ; Moberg R; Svensson S; Aksela S; Sairanen O; Kivimäki A; Naves de Brito A ; Nõmmiste E; Jauhiainen J; Aksela H
    Phys Rev A; 1995 Jan; 51(1):855-858. PubMed ID: 9911650
    [No Abstract]   [Full Text] [Related]  

  • 68. Targeting claudin-4 enhances CDDP-chemosensitivity in gastric cancer.
    Nishiguchi Y; Fujiwara-Tani R; Sasaki T; Luo Y; Ohmori H; Kishi S; Mori S; Goto K; Yasui W; Sho M; Kuniyasu H
    Oncotarget; 2019 Mar; 10(22):2189-2202. PubMed ID: 31040910
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Colon epithelial cell TGFβ signaling modulates the expression of tight junction proteins and barrier function in mice.
    Marincola Smith P; Choksi YA; Markham NO; Hanna DN; Zi J; Weaver CJ; Hamaamen JA; Lewis KB; Yang J; Liu Q; Kaji I; Means AL; Beauchamp RD
    Am J Physiol Gastrointest Liver Physiol; 2021 Jun; 320(6):G936-G957. PubMed ID: 33759564
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Role of Nuclear Claudin-4 in Renal Cell Carcinoma.
    Owari T; Sasaki T; Fujii K; Fujiwara-Tani R; Kishi S; Mori S; Mori T; Goto K; Kawahara I; Nakai Y; Miyake M; Luo Y; Tanaka N; Kondoh M; Fujimoto K; Kuniyasu H
    Int J Mol Sci; 2020 Nov; 21(21):. PubMed ID: 33172177
    [TBL] [Abstract][Full Text] [Related]  

  • 71. TGF-β induces GBM mesenchymal transition through upregulation of CLDN4 and nuclear translocation to activate TNF-α/NF-κB signal pathway.
    Yan T; Tan Y; Deng G; Sun Z; Liu B; Wang Y; Yuan F; Sun Q; Hu P; Gao L; Tian D; Chen Q
    Cell Death Dis; 2022 Apr; 13(4):339. PubMed ID: 35418179
    [TBL] [Abstract][Full Text] [Related]  

  • 72. The E-Cadherin and N-Cadherin Switch in Epithelial-to-Mesenchymal Transition: Signaling, Therapeutic Implications, and Challenges.
    Loh CY; Chai JY; Tang TF; Wong WF; Sethi G; Shanmugam MK; Chong PP; Looi CY
    Cells; 2019 Sep; 8(10):. PubMed ID: 31547193
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Metformin attenuates transforming growth factor beta (TGF-β) mediated oncogenesis in mesenchymal stem-like/claudin-low triple negative breast cancer.
    Wahdan-Alaswad R; Harrell JC; Fan Z; Edgerton SM; Liu B; Thor AD
    Cell Cycle; 2016; 15(8):1046-59. PubMed ID: 26919310
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Mechanisms of TGFβ-Induced Epithelial-Mesenchymal Transition.
    Moustakas A; Heldin CH
    J Clin Med; 2016 Jun; 5(7):. PubMed ID: 27367735
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Dihydroartemisinin inhibits catabolism in rat chondrocytes by activating autophagy via inhibition of the NF-κB pathway.
    Jiang LB; Meng DH; Lee SM; Liu SH; Xu QT; Wang Y; Zhang J
    Sci Rep; 2016 Dec; 6():38979. PubMed ID: 27941926
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Non-coding RNAs participate in the regulatory network of CLDN4 via ceRNA mediated miRNA evasion.
    Song YX; Sun JX; Zhao JH; Yang YC; Shi JX; Wu ZH; Chen XW; Gao P; Miao ZF; Wang ZN
    Nat Commun; 2017 Aug; 8(1):289. PubMed ID: 28819095
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Feedback regulation of TGF-β signaling.
    Yan X; Xiong X; Chen YG
    Acta Biochim Biophys Sin (Shanghai); 2018 Jan; 50(1):37-50. PubMed ID: 29228156
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Gamma synuclein is a novel Twist1 target that promotes TGF-β-induced cancer cell migration and invasion.
    Shao T; Song P; Hua H; Zhang H; Sun X; Kong Q; Wang J; Luo T; Jiang Y
    Cell Death Dis; 2018 May; 9(6):625. PubMed ID: 29795373
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The TNF Family of Ligands and Receptors: Communication Modules in the Immune System and Beyond.
    Dostert C; Grusdat M; Letellier E; Brenner D
    Physiol Rev; 2019 Jan; 99(1):115-160. PubMed ID: 30354964
    [TBL] [Abstract][Full Text] [Related]  

  • 80. IL1-Induced JAK/STAT Signaling Is Antagonized by TGFβ to Shape CAF Heterogeneity in Pancreatic Ductal Adenocarcinoma.
    Biffi G; Oni TE; Spielman B; Hao Y; Elyada E; Park Y; Preall J; Tuveson DA
    Cancer Discov; 2019 Feb; 9(2):282-301. PubMed ID: 30366930
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.